Cortex
About Cortex
Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient’s disease pathophysiology through their innovative OptiMap™ System. This system is a 510(k) cleared, electrographic flow (EGF) mapping solution designed with AI, enabling physicians to See What Matters in the complex electrical conduction of atrial fibrillation.
Technology and Mission
The OptiMap™ System uses an advanced mapping system that calculates Electrographic Flow™ from unipolar electrogram signals recorded via the 64-electrode OptiMap™ basket catheter. It applies a novel optical flow algorithm to reconstruct the chaotic electrical conduction, thereby facilitating personalized treatment strategies. This technology aims to optimize ablation strategies in atrial fibrillation treatment, reducing unnecessary tissue destruction and improving clinical success by phenotyping patients individually.
Leadership and Innovation
Cortex leverages multimodal AI in medical technology to drive innovations impacting patient outcomes. The company boasts a scientific advisory board and leadership that includes renowned experts such as Dr. Matthew Lungren from Microsoft Health & Life Sciences and other prominent physicians in cardiac electrophysiology.